New Orleans, LA
Ncardia is excited to join the ASGCT 2025 Annual Meeting in New Orleans this May! This event is a must-attend for anyone passionate about gene and cell therapy, with tons of opportunities to connect with leading experts and discover the latest breakthroughs in the field. We’re looking forward to discussing how our iPSC-based models are helping to shape safer, more effective therapies.
The conference promises to be a great mix of innovative research, networking, and interactive sessions. Whether you're presenting your work, meeting new collaborators, or exploring the latest advancements, we can't wait to be part of this exciting event. See you in New Orleans!
Exclusive ASGCT Posters and Presentations
Attend our poster presentations and scientific talks to explore how Ncardia is advancing iPSC-based innovation across disease modeling, cell therapy, and drug discovery. From scalable manufacturing to 3D cardiac microtissues, our experts are sharing new data and insights you won’t want to miss.
*Please Note: All times are listed in Central Time (CT).
"Human iPSC-Derived Cardiomyocyte Disease Modeling of Friedreich’s Ataxia and Duchenne Muscular Dystrophy for Therapeutic Assessment "
AMA1535
Session: Wednesday Poster Reception
Date: May 14, 2025
Time: 5:30 PM - 7:00 PM
Room: Poster Hall Hall I2
"Scalable and Consistent Manufacturing of Functional Lung Cells from iPSCs: Ncardia's Advanced Differentiation Protocols for Drug Discovery and Tissue Engineering "
AMA1530
Session: Wednesday Poster Reception
Date: May 14, 2025
Time: 5:30 PM - 7:00 PM
Room: Poster Hall Hall I2
TALK: “Scalable Production of Hematopoietic Stem Cells and Microglia from iPSCs Using Stirred Tank Bioreactors for Consistent Cell Therapy Manufacturing ”
Session: Cell Therapy Product Engineering II
Date: May 16, 2025
Time: 3:45 PM - 5:40 PM
Room: Room 293-296
Abstract Presentation: 5:15 PM - 5:30 PM
TALK: “Advancing Cardiovascular Drug discovery with iPSC-Derived 3D Cardiac Microtissues in High-Throughput Screening ”
Session: Organoids and iPSC Disease Modeling for Drug Discovery
Date: May 15, 2025
Time: 3:45 PM - 5:30 PM
Room: Room 291-292
Abstract Presentation: 5:00 PM - 5:15 PM
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.